Entering text into the input field will update the search result below

GlycoMimetics, Inc. (GLYC) CEO Harout Semerjian on Q3 2021 Results - Earnings Call Transcript

Nov. 02, 2021 2:50 PM ETGlycoMimetics, Inc. (GLYC)
SA Transcripts profile picture
SA Transcripts

GlycoMimetics, Inc. (NASDAQ:GLYC) Q3 2021 Earnings Conference Call November 2, 2021 8:30 AM ET

Company Participants

Shari Annes - IR

Harout Semerjian - CEO, President & Director

Eric Feldman - SVP & Chief Medical Officer

Brian Hahn - SVP & CFO

Conference Call Participants

Edward White - H.C. Wainwright & Co.

Zegbeh Jallah - ROTH Capital Partners

Jiale Song - Jefferies


Good morning, and thank you all for joining the GlycoMimetics call. [Operator Instructions]. I would now like to turn the call over to Ms. Shari Annes of the Investor Relations Group at GlycoMimetics. Please go ahead.

Shari Annes

Good morning. Today, we will review our accomplishments and financial results for the period ended September 30, 2021. We'll also update you on recent achievements. The press release we issued this morning is available on the company's website at www.glycomimetics.com under the Investors tab.

This call is being recorded. A dial-in phone replay will be available for 24 hours after the close of the call. The webcast replay will also be available for 30 days in the Investor Relations section of the company's website.

Joining me on the call today from GlycoMimetics are Harout Semerjian, Chief Executive Officer; Dr. Eric Feldman, Chief Medical Officer; and Brian Hahn, Chief Financial Officer. We'll start today's call with comments from Harout and then Eric. Brian will then follow to provide an overview of the company's financial position, and then we'll open the call to Q&A.

I'd like to remind you that today's call will include forward-looking statements based on current expectations. Forward-looking statements contained on this call include, but are not limited to, statements about the company's product candidates, uproleselan, GMI-1359 and GMI-1687, and our other pipeline programs, along with statements about expectations regarding our operations, plans for future development and potential commercialization and cash position.

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.